Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.905
-0.145 (-4.75%)
Aug 1, 2025, 5:07 PM CET

Accolade Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1221023850109-
Upgrade
Market Cap Growth
167.21%167.21%-23.60%-54.48%--
Upgrade
Enterprise Value
11799384577-
Upgrade
Last Close Price
2.903.751.603.106.64-
Upgrade
PS Ratio
154.78128.7826.0226.50152.22-
Upgrade
PB Ratio
23.2419.335.725.233.61-
Upgrade
P/TBV Ratio
29.2224.318.457.914.05-
Upgrade
EV/Sales Ratio
148.58125.5626.2623.77106.59-
Upgrade
Debt / Equity Ratio
-----0.15
Upgrade
Asset Turnover
0.110.110.150.090.04-
Upgrade
Quick Ratio
5.165.163.475.4918.721.00
Upgrade
Current Ratio
5.215.213.485.5918.811.05
Upgrade
Return on Equity (ROE)
-188.57%-188.57%-122.66%-134.47%-102.07%-128.36%
Upgrade
Return on Assets (ROA)
-69.05%-69.05%-41.32%-26.03%-31.14%-31.74%
Upgrade
Return on Capital (ROIC)
-85.02%-85.02%-49.36%-27.90%-33.83%-37.13%
Upgrade
Earnings Yield
-9.19%-11.05%-26.08%-53.74%-15.72%-
Upgrade
Buyback Yield / Dilution
-20.66%-20.66%-22.29%-31.86%-30.89%-
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.